rs34729771

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_005055.5(RAPSN):​c.691-11delC variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 30441 hom., cov: 0)
Exomes 𝑓: 0.70 ( 351164 hom. )

Consequence

RAPSN
NM_005055.5 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0750

Publications

8 publications found
Variant links:
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
RAPSN Gene-Disease associations (from GenCC):
  • fetal akinesia deformation sequence 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • neuromuscular disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • congenital myasthenic syndrome 11
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-47441931-AG-A is Benign according to our data. Variant chr11-47441931-AG-A is described in ClinVar as Benign. ClinVar VariationId is 197249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAPSNNM_005055.5 linkc.691-11delC intron_variant Intron 3 of 7 ENST00000298854.7 NP_005046.2 Q13702-1A0A0S2Z4F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAPSNENST00000298854.7 linkc.691-11delC intron_variant Intron 3 of 7 1 NM_005055.5 ENSP00000298854.2 Q13702-1

Frequencies

GnomAD3 genomes
AF:
0.614
AC:
93335
AN:
152042
Hom.:
30426
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.381
Gnomad AMI
AF:
0.868
Gnomad AMR
AF:
0.663
Gnomad ASJ
AF:
0.716
Gnomad EAS
AF:
0.659
Gnomad SAS
AF:
0.786
Gnomad FIN
AF:
0.606
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.720
Gnomad OTH
AF:
0.673
GnomAD2 exomes
AF:
0.679
AC:
114250
AN:
168348
AF XY:
0.693
show subpopulations
Gnomad AFR exome
AF:
0.378
Gnomad AMR exome
AF:
0.618
Gnomad ASJ exome
AF:
0.723
Gnomad EAS exome
AF:
0.642
Gnomad FIN exome
AF:
0.605
Gnomad NFE exome
AF:
0.722
Gnomad OTH exome
AF:
0.724
GnomAD4 exome
AF:
0.703
AC:
989419
AN:
1407860
Hom.:
351164
Cov.:
0
AF XY:
0.706
AC XY:
491770
AN XY:
696436
show subpopulations
African (AFR)
AF:
0.372
AC:
12221
AN:
32854
American (AMR)
AF:
0.626
AC:
23277
AN:
37186
Ashkenazi Jewish (ASJ)
AF:
0.720
AC:
18181
AN:
25262
East Asian (EAS)
AF:
0.596
AC:
22653
AN:
37980
South Asian (SAS)
AF:
0.769
AC:
61864
AN:
80442
European-Finnish (FIN)
AF:
0.618
AC:
26090
AN:
42222
Middle Eastern (MID)
AF:
0.738
AC:
3014
AN:
4082
European-Non Finnish (NFE)
AF:
0.717
AC:
780855
AN:
1089296
Other (OTH)
AF:
0.705
AC:
41264
AN:
58536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
18011
36022
54034
72045
90056
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19538
39076
58614
78152
97690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.614
AC:
93390
AN:
152160
Hom.:
30441
Cov.:
0
AF XY:
0.613
AC XY:
45596
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.381
AC:
15800
AN:
41492
American (AMR)
AF:
0.663
AC:
10148
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.716
AC:
2486
AN:
3472
East Asian (EAS)
AF:
0.658
AC:
3399
AN:
5166
South Asian (SAS)
AF:
0.784
AC:
3785
AN:
4826
European-Finnish (FIN)
AF:
0.606
AC:
6423
AN:
10604
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.720
AC:
48917
AN:
67986
Other (OTH)
AF:
0.677
AC:
1432
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1742
3485
5227
6970
8712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.686
Hom.:
6621
Bravo
AF:
0.604
Asia WGS
AF:
0.720
AC:
2505
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 21, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital Myasthenic Syndrome, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fetal akinesia deformation sequence 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fetal akinesia deformation sequence 1;C4225367:Congenital myasthenic syndrome 11 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fetal akinesia deformation sequence 2 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 11 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.075
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34729771; hg19: chr11-47463483; API